Margaret M. Tarpey
Corporate Officer/Principal chez University of Pittsburgh
Profil
Margaret M.
Tarpey is the founder of Complexa, Inc. (founded in 2008).
She is currently a Professor at the University of Pittsburgh (since 2013).
Dr. Tarpey's education includes an undergraduate degree from the University of California, Riverside and a graduate degree from the University of California San Diego.
Postes actifs de Margaret M. Tarpey
| Sociétés | Poste | Début |
|---|---|---|
| University of Pittsburgh | Corporate Officer/Principal | - |
Anciens postes connus de Margaret M. Tarpey
| Sociétés | Poste | Fin |
|---|---|---|
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Fondateur | - |
Formation de Margaret M. Tarpey
| University of California, Riverside | Undergraduate Degree |
| University of California San Diego | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
